9/4
08:30 am
lixt
LIXTE Receives U.S. Patent Issue Notification for Immune Oncology
Medium
Report
LIXTE Receives U.S. Patent Issue Notification for Immune Oncology
8/26
08:30 am
lixt
First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company
Medium
Report
First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company